Xanomeline and Trospium Chloride Capsules clinical trials

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

This study looks at the long-term safety of a new medicine, KarXT, for people with schizophrenia whose current treatment isn't working well enough. It's for those who have already started in a previous related study.